Methylenetetrahydrofolate Reductase Gene Polymorphisms and Cardiovascular Diseases

Cell & Developmental Biology
doi 10.4172/2168-9296.1000172
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Associations Between 2 Polymorphisms in the Methylenetetrahydrofolate Reductase Gene and Placental Abruption

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2007English

Methylenetetrahydrofolate Reductase Gene Polymorphisms in Turkish Children With Attention-Deficit/Hyperactivity Disorder

Genetic Testing and Molecular Biomarkers
MedicineGenetics
2012English

Thiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia

Turkish Journal of Haematology
Hematology
2015English

The End of a Long Debate: Methylenetetrahydrofolate Reductase Gene Polymorphisms Do Not Increase Thrombosis Risk

Eurasian Journal of Medicine
Medicine
2017English

Interplay Between 3′-Utr Polymorphisms in the Methylenetetrahydrofolate Reductase (MTHFR) Gene and the Risk of Ischemic Stroke

Scientific Reports
Multidisciplinary
2017English

Methylenetetrahydrofolate Reductase Haplotype Tag Single-Nucleotide Polymorphisms and Risk of Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2006English

SIRT1 Gene Polymorphisms Affect the Protein Expression in Cardiovascular Diseases

PLoS ONE
Multidisciplinary
2014English

Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Risk of Molecularly Defined Subtypes of Childhood Acute Leukemia

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Β1- And Β2-Adrenoceptor Polymorphisms and Cardiovascular Diseases

British Journal of Pharmacology
Pharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy